Fundraising FoxID Ventures — 2023 Investments
1 investments dated 2023 · listed companies and verified rows first · show all
Alerjealerje.comin𝕏Aug 2023
Alerje develops FAIT, a mobile app and clinical platform for food allergy oral immunotherapy (OIT), offering dose tracking, HIPAA-compliant clinic messaging, and predictive insights.
Digital HealthHealthtechMedical DevicesDetroit, US
Javier Evelyn(Founder & CEO)in
Board seatPatti Glaza· per SEC Form D
Co-investorsBackstage CapitalChloe CapitalJumpstart NovaMichigan RiseSeae VenturesBlue Victor Capital+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.